BeiGene

BeiGene

BeiGene

BeiGene is a Chinese life sciences biotechnology company based in Beijing that is focused on discovering and developing innovative oncology drugs that will address unmet medical needs in cancers that are prevalent in China and the AsiaPacific region..
Founded
2010
Raised
$185M
Follow us
Featured on
Alexa global traffic share
Latest funding
$185,000,000
Post-IPO equity - 2016
Team Size
50+
Employees
Location
Headquarters
Xconomy

Celgene Builds Up Cancer Drug Pipeline With BeiGene Deal

Health
$185,000,000 Post-IPO equity
Seeking Alpha

Week In Review: Beijing's BeiGene Raises $185 Million For Clinical Trial Program